EDGAR Filing Documents for 0001193125-09-100028

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001193125-09-100028

Filing Date

2009-05-05

Accepted

2009-05-05 16:43:14

Documents

Period of Report

2008-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO FORM 10-Q	d10qa.htm	10-Q/A	25490
2	ASSET PURCHASE AGREEMENT AND AMENDMENT NO.1 TO ASSET PURCHASE AGREEMENT	dex105.htm	EX-10.5	662358
3	ASSET PURCHASE AGREEMENT BETWEEN THE COMPANY AND GMN, INC.	dex106.htm	EX-10.6	694221
4	CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A)	dex313.htm	EX-31.3	2272
5	CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A)	dex314.htm	EX-31.4	2276
6	GRAPHIC	g80891g93g46.jpg	GRAPHIC	13036
	Complete submission text file	0001193125-09-100028.txt		1406246

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451

Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500

PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)